Myriad Genetics Inc financial data

Symbol
MYGN on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
322 North 2200 West, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 191 % +22.9%
Quick Ratio 17 % +35.8%
Debt-to-equity 46.8 % -12.1%
Return On Assets -11.8 % +47.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91.3M shares +0.89%
Common Stock, Shares, Outstanding 91.3M shares +1.56%
Entity Public Float 2.22B USD +17%
Common Stock, Value, Issued 900K USD 0%
Weighted Average Number of Shares Outstanding, Basic 90.6M shares +9.42%
Weighted Average Number of Shares Outstanding, Diluted 90.6M shares +9.42%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 838M USD +11.2%
Research and Development Expense 113M USD +27.8%
Costs and Expenses 939M USD -7.23%
Operating Income (Loss) -124M USD +52%
Nonoperating Income (Expense) 0 USD +88.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -124M USD +52.9%
Income Tax Expense (Benefit) 3.8M USD +245%
Net Income (Loss) Attributable to Parent -127M USD +51.7%
Earnings Per Share, Basic -1.41 USD/shares +55.7%
Earnings Per Share, Diluted -1.41 USD/shares +55.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 102M USD -22.5%
Marketable Securities, Current 0 USD -100%
Cash, Cash Equivalents, and Short-term Investments 141M USD -17%
Accounts Receivable, after Allowance for Credit Loss, Current 121M USD +6.04%
Inventory, Net 27.5M USD +25%
Assets, Current 298M USD -4.97%
Property, Plant and Equipment, Net 117M USD -1.35%
Operating Lease, Right-of-Use Asset 55M USD -10.7%
Intangible Assets, Net (Excluding Goodwill) 262M USD -24.9%
Goodwill 286M USD -0.38%
Other Assets, Noncurrent 8.5M USD -44.8%
Assets 1.03B USD -10.4%
Accounts Payable, Current 32.3M USD +25.2%
Employee-related Liabilities, Current 57.4M USD +15.5%
Accrued Liabilities, Current 119M USD +4.48%
Contract with Customer, Liability, Current 500K USD -16.7%
Liabilities, Current 164M USD +5.26%
Deferred Income Tax Liabilities, Net 2.7M USD -74.3%
Operating Lease, Liability, Noncurrent 87.9M USD -9.75%
Other Liabilities, Noncurrent 2.2M USD -94.7%
Liabilities 327M USD -10.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -800K USD +78.4%
Retained Earnings (Accumulated Deficit) -757M USD -20.2%
Stockholders' Equity Attributable to Parent 701M USD -10.5%
Liabilities and Equity 1.03B USD -10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.6M USD +44%
Net Cash Provided by (Used in) Financing Activities -8.8M USD -79.6%
Net Cash Provided by (Used in) Investing Activities -7.1M USD -121%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 91.3M shares +1.56%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -35.3M USD -970%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 112M USD -20.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 200K USD
Deferred Tax Assets, Valuation Allowance 112M USD +17.8%
Deferred Tax Assets, Gross 185M USD -5.08%
Operating Lease, Liability 101M USD
Depreciation 19.5M USD +2.09%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -124M USD +51.8%
Lessee, Operating Lease, Liability, to be Paid 142M USD -12.1%
Property, Plant and Equipment, Gross 227M USD -4.98%
Operating Lease, Liability, Current 12.8M USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD -31.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.9M USD -16%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 41M USD -13.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12.3M USD +6.03%
Deferred Tax Assets, Operating Loss Carryforwards 62.7M USD -18.7%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 51.7M USD +7.48%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.4M USD +5.98%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 42.1M USD -1.64%
Deferred Tax Assets, Net of Valuation Allowance 73.2M USD -26.8%
Interest Expense 2.9M USD +3.57%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%